Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Mr Nigussie Bogale,
Mr Jean-Claude Daubert,
Presenter | see Discussant report
Nigussie Bogale, (Norway)Presentation webcast
List of Authors: Kenneth Dickstein,Nigussie Bogale,Silvia Priori,Angelo Auricchio,John G. Cleland, Anselm Gitt, Tobias Limbourg,Cecilia Linde, Dirk J van Veldhuisen, Josep Brugada Abstract: European Cardiac Resynchronization Therapy Survey Aims: The European CRT Survey is a joint initiative undertaken by the Heart Failure Association (HFA) and the European Heart Rhythm Association (EHRA) of the European Society of Cardiology. The primary aim of this Survey is to describe current European practice in terms of CRT implantations. Methods and results: 141 centres from 13 European countries contributed data from consecutive patients successfully implanted with a CRT device with or without an ICD between November 2008 and June 2009. 2438 patients were enrolled. The median age of patients was 70 years (IQR 62-76) and 31 % were = 75 years. 78 % were in NYHA functional class III or IV and 22 % in I or II. The mean ejection fraction was 27±8% and the mean QRS duration 157±32 ms. QRS duration was <120 ms in 9%. Atrial fibrillation was reported in 23%. 26% of patients had a previously implanted permanent pacemaker or ICD. 76% of procedures were performed by an electrophysiologist. 82% had an elective admission for implantation and the median duration of hospitalisation was 3 days (IQR 2-7). 73% received a CRT-D device which was more often implanted in men, younger patients and with ischaemic aetiology. The mean QRS duration was reduced to 133±27 ms (p<0.0001) at discharge. Peri-procedural complication rates were comparable to the rates reported in randomized trials. Conclusion: This CRT Survey provides important information describing current European practice with regard to patient demographics, selection criteria, procedural routines and status at discharge. These data should be useful for benchmarking individual patient management and national practice against wider experience.
Discussant | see Presenter abstract
Jean-Claude Daubert, FESC (France)
European CRT Survey
This congress report accompanies a presentation given at the ESC Congress 2009. Written by the author himself/herself, this report does not necessarily reflect the opinion of the European Society of Cardiology.